Moreover, in late 2010, SNY’s top executives (Chris Viehbacher and Hanspeter Spek) ridiculed Amhastar’s capabilities with respect to Lovenox during an investor conference call. Of the iHub posters I respect, Peter (biomaven) is probably the only one who thinks Amphastar figured out how to make Lovenox by playing fair and square.